UNSPSC 51294907: Tienopramine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36L0QUK8SY. European Medicines Agency schedules Tienopramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11034MIG. Tienopramine generally arises in the molecular formula C17H20N2S.

UNSPSC 51294907 Tienopramine is a Commodity code, but the recent state and local opportunities posted under it do not align with tienopramine procurement — instead, they reflect solicitations for naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through cooperative purchasing and direct pharmacy programs. The code shows a mismatch between its nominal scope and actual buying activity, making it difficult to characterize tienopramine-specific demand. When opportunities do appear under pharmaceutical codes in state and local procurement, the work typically involves bulk purchasing of FDA-compliant products through authorized wholesalers, compliance with cGMP and drug supply chain security standards, negotiated pricing through multiple distribution channels, and multi-year contracts with performance penalties and administrative fees.

Recent activity centers on cooperative purchasing vehicles and state health agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring vendors to supply through AmerisourceBergen, Cardinal Health, and Morris & Dickson with pricing weighted 75 percent on competitiveness; Seminole County, Florida released an IFB in June 2026 for naloxone and drug deactivation systems with a July 26, 2023 response deadline; and the Texas Health and Human Services Commission posted an RFI in April 2026 exploring direct-to-manufacturer prescription programs to inform future solicitation strategy. Activity is concentrated in state health and human services departments and regional cooperative purchasing organizations, with geographic presence in Texas, Minnesota, Oregon, and Florida. The mismatch between code taxonomy and actual solicitations suggests that tienopramine opportunities, if they exist in state and local procurement, are not appearing in the posted record at this time.